Skip to main content
. Author manuscript; available in PMC: 2011 Mar 25.
Published in final edited form as: J Neurosurg. 2009 Mar;110(3):572–582. doi: 10.3171/2008.7.JNS08475

Fig. 3.

Fig. 3

A: Two representative dot plots showing CD45 and CD11b staining for cortex overlying tumor by flow cytometry. Similar types of CD45 and CD11b positive and negative cells can be seen as for enhancing tumor, but the absolute number of inflammatory cells is much lower. B: Summary scatter plot demonstrating the percentage of viable cells that are CD45+/CD11b, CD45dim/CD11b+, and CD45bright/CD11b+. Each shape represents a tumor specimen taken from a specific patient.